Although many previous studies showed that obesity was associated with both aggressiveness of PCa at the time of diagnosis and decreased BCR-free survival10–13, the relationship between BMI and BCR is still debatable, as a significant number of prior studies failed to show an association between increased risk of BCR and higher BMI14,15. This evidence concerns the gene BCR and obesity due to melanocortin 4 receptor deficiency.